Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Tuberculosis

Free Subscription Articles published in J Infect Retrieve available abstracts of 47 articles: HTML format

Single Articles

July 2022
1. DHANA A, Hamada Y, Kengne AP, Kerkhoff AD, et al
   Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
   J Infect. 2022;85:40-48.
   PubMed     Abstract available
   
   
   June 2022
2. TUNESI S, Du DL, Gualano G, Millet JP, et al
   Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
   J Infect. 2022;84:834-872.
   PubMed    
   
   
   May 2022
3. BACHIR M, Guglielmetti L, Tunesi S, Billard-Pomares T, et al
   Molecular detection of isoniazid monoresistance improves tuberculosis treatment: a retrospective cohort in France.
   J Infect. 2022 May 20. pii: S0163-4453(22)00306.
   PubMed     Abstract available
   
   
   
4. WYLLIE D, Do T, Myers R, Nikolayevskyy V, et al
   M. tuberculosis microvariation is common and is associated with transmission: analysis of three years prospective universal sequencing in England.
   J Infect. 2022 May 17. pii: S0163-4453(22)00294.
   PubMed     Abstract available
   
   
   
5. CHEN Y, Liu Q, Takiff HE, Gao Q, et al
   Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission.
   J Infect. 2022 May 16. pii: S0163-4453(22)00293.
   PubMed     Abstract available
   
   
   April 2022
6. LIU Q, Chen X, Liu X, Yang D, et al
   Cervical lymph node dissection on the treatment of cervical tuberculosis.
   J Infect. 2022 Apr 25. pii: S0163-4453(22)00242.
   PubMed    
   
   
   January 2022
7. LUO Y, Xue Y, Song H, Tang G, et al
   Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection.
   J Infect. 2022 Jan 4. pii: S0163-4453(21)00666.
   PubMed     Abstract available
   
   
   
8. LUCEY O, Potter J, Ricketts W, Castle L, et al
   Utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis in East London.
   J Infect. 2022;84:17-23.
   PubMed     Abstract available
   
   
   October 2021
9. MONICA R, Lin NW, Laura D, Fidelma F, et al
   Latent tuberculosis infection amongst patients with rheumatic diseases in an Irish Tertiary Referral Centre - A five-year review.
   J Infect. 2021 Oct 27. pii: S0163-4453(21)00510.
   PubMed    
   
   
   August 2021
10. DAI Y, Xie L, Wang X, Zhang H, et al
    Depression increases the risk of tuberculosis: preliminary observations.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00369.
    PubMed    
    
    
    July 2021
11. CHENDI BH, Tveiten H, Snyders CI, Tonby K, et al
    CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries.
    J Infect. 2021 Jul 29. pii: S0163-4453(21)00379.
    PubMed     Abstract available
    
    
    
12. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    PubMed     Abstract available
    
    
    
13. TAN Y, Deng Y, Yan X, Liu F, et al
    Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study.
    J Infect. 2021;83:46-53.
    PubMed     Abstract available
    
    
    
14. SONG Y, Dong Y, Liao Y, Liang Z, et al
    Apoptotic caspases suppress Mycobacterium bovis-induced IFN-beta production in murine macrophage.
    J Infect. 2021;83:61-68.
    PubMed     Abstract available
    
    
    May 2021
15. DILLARD LK, Martinez RX, Perez LL, Fullerton AM, et al
    Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review: Ototoxic hearing loss in drug-resistant tuberculosis.
    J Infect. 2021 May 17. pii: S0163-4453(21)00252.
    PubMed     Abstract available
    
    
    
16. SAM IK, Chen YY, Ma J, Li SY, et al
    TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.
    J Infect. 2021 May 2. pii: S0163-4453(21)00219.
    PubMed     Abstract available
    
    
    February 2021
17. LIU Q, Fang X, Chen X, Dai X, et al
    Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
    J Infect. 2021 Feb 20. pii: S0163-4453(21)00092.
    PubMed    
    
    
    
18. WANG G, Jiang G, Jing W, Zong Z, et al
    Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey.
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00055.
    PubMed     Abstract available
    
    
    
19. PATTERSON B, Abbara A, Collin S, Henderson M, et al
    Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
    J Infect. 2021;82:240-244.
    PubMed     Abstract available
    
    
    January 2021
20. LOGAN C, Mullender C, Mirfenderesky M, Feasey N, et al
    Presentations and outcomes of central nervous system TB in a UK cohort: The high burden of neurological morbidity.
    J Infect. 2021;82:90-97.
    PubMed     Abstract available
    
    
    
21. AHN CS, Shin JW, Kim JG, Lee WY, et al
    Spectrum of pleuropulmonary paragonimiasis: An analysis of 685 cases diagnosed over 22 years.
    J Infect. 2021;82:150-158.
    PubMed     Abstract available
    
    
    
22. HEAD IM, Lazarus R
    Use of Xpert MTB/RIF in a low prevalence setting in the Southwest of England.
    J Infect. 2021;82:159-198.
    PubMed    
    
    
    December 2020
23. IZZARD A, Wilders S, Smith C, Wickers M, et al
    Improved treatment completion for Tuberculosis patients: the case for a dedicated social care team.
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30780.
    PubMed     Abstract available
    
    
    
24. MARINE E, Loic H, Christelle GC, Pierre-Louis N, et al
    Improving tuberculosis management in prisons: impact of a rapid molecular point-of-care test.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30764.
    PubMed     Abstract available
    
    
    
25. ADANKWAH E, Nausch N, Minadzi D, Abass MK, et al
    Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30729.
    PubMed     Abstract available
    
    
    
26. LIU XH, Xia L, Song B, Wang H, et al
    Stool-based Xpert MTB/RIF Ultra Assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30727.
    PubMed     Abstract available
    
    
    November 2020
27. VAN ZYL CW, Loots DT, Solomons R, van Reenen M, et al
    Metabolic characterization of tuberculous meningitis in a South African paediatric population using (1)H NMR metabolomics.
    J Infect. 2020;81:743-752.
    PubMed     Abstract available
    
    
    September 2020
28. SUDBURY EL, Clifford V, Messina NL, Song R, et al
    Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    J Infect. 2020 Sep 29. pii: S0163-4453(20)30631.
    PubMed     Abstract available
    
    
    August 2020
29. SHI CL, Han P, Tang PJ, Chen MM, et al
    Clinical Metagenomic Sequencing for etiological diagnosis in pulmonary tuberculosis suspects.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30537.
    PubMed     Abstract available
    
    
    
30. CAPOCCI SJ, Sewell J, Smith C, Cropley I, et al
    Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.
    J Infect. 2020;81:289-296.
    PubMed     Abstract available
    
    
    July 2020
31. KOMIYA K, Yamasue M, Takahashi O, Hiramatsu K, et al
    The COVID-19 pandemic and the true incidence of tuberculosis in Japan.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30462.
    PubMed    
    
    
    June 2020
32. KIM H, Kim SH, Jung JH, Kim MJ, et al
    The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: a quasi-experimental study.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30452.
    PubMed     Abstract available
    
    
    
33. MCGUIRE E, Rajagopal S, Vaikanthanathan T, Krutikov M, et al
    Extraspinal Articular Tuberculosis: an 11-year Retrospective Study of Demographic Features and Clinical Outcomes in East London.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30422.
    PubMed     Abstract available
    
    
    
34. LAI CC, Yu WL
    The COVID-19 Pandemic and Tuberculosis in Taiwan.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30397.
    PubMed    
    
    
    May 2020
35. ZHOU X, Zhang L, Lie L, Zhang Z, et al
    MxA suppresses TAK1-IKKalpha/beta-NF-kappaB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection.
    J Infect. 2020 May 20. pii: S0163-4453(20)30286.
    PubMed     Abstract available
    
    
    April 2020
36. LUO Y, Tang G, Lin Q, Mao L, et al
    Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30264.
    PubMed     Abstract available
    
    
    
37. ESTEVEZ O, Anibarro L, Garet E, Martinez A, et al
    Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection.
    J Infect. 2020 Apr 21. pii: S0163-4453(20)30218.
    PubMed     Abstract available
    
    
    
38. HO J, Bokil NJ, Nguyen PTB, Nguyen TA, et al
    A Transcriptional Blood Signature Distinguishes Early Tuberculosis Disease from Latent Tuberculosis Infection and Uninfected Individuals in a Vietnamese Cohort.
    J Infect. 2020 Apr 21. pii: S0163-4453(20)30221.
    PubMed     Abstract available
    
    
    March 2020
39. HU Y, Wen Z, Liu S, Cai Y, et al
    Ibrutinib Suppresses Intracellular Mycobacterium Tuberculosis Growth by Inducing Macrophage Autophagy.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30115.
    PubMed     Abstract available
    
    
    February 2020
40. PETRUCCIOLI E, Chiacchio T, Navarra A, Vanini V, et al
    Effect of HIV-infection on QuantiFERON-Plus accuracy in patients with active tuberculosis and latent infection: QFT-Plus in HIV infected individuals.
    J Infect. 2020 Feb 22. pii: S0163-4453(20)30093.
    PubMed     Abstract available
    
    
    
41. SUZUKAWA M, Takeda K, Akashi S, Asari I, et al
    Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
    J Infect. 2020 Feb 22. pii: S0163-4453(20)30092.
    PubMed     Abstract available
    
    
    January 2020
42. PERETOKINA I, Krylova LY, Antonova OV, Kholina MS, et al
    Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
    J Infect. 2020 Jan 22. pii: S0163-4453(20)30031.
    PubMed     Abstract available
    
    
    
43. ZHOU Y, Anthony R, Wang S, Ou X, et al
    The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives.
    J Infect. 2020 Jan 20. pii: S0163-4453(20)30022.
    PubMed     Abstract available
    
    
    
44. CAMPRUBI D, Gomila A, Grijota-Camino MD, Soldevila L, et al
    Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by Real-time Polymerase Chain Reaction, Xpert(R)MTB/RIF.
    J Infect. 2020 Jan 16. pii: S0163-4453(20)30026.
    PubMed     Abstract available
    
    
    October 2019
45. SEKYERE JO, Reta MA, Maningi NE, Fourie PB, et al
    Molecular Epidemiology, Diagnostics and Mechanisms of Antibiotic Resistance in Mycobacterium tuberculosis complex in Africa: A Systematic Review of Current Reports.
    J Infect. 2019 Oct 16. pii: S0163-4453(19)30316.
    PubMed     Abstract available
    
    
    
46. KARMAKAR M, Trauer JM, Ascher DB, Denholm JT, et al
    Hyper transmission of Beijing lineage Mycobacterium tuberculosis: Systematic review and Meta-analysis.
    J Infect. 2019 Oct 1. pii: S0163-4453(19)30287.
    PubMed     Abstract available
    
    
    September 2019
47. MANALAN K, Green N, Arnold A, Cooke GS, et al
    A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK.
    J Infect. 2019 Sep 21. pii: S0163-4453(19)30277.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: